semaglutide from hers Hims & falls 8% as FDA issues warning letter over compounded weight loss drug Hims & Hers to bring

Diabetes Care 47(Suppl 1):S145S157

Being a triple agonist receptor, GLP3-R activates multiple hormonal receptors at once and offers broader signaling activity compared to more selective peptides like tirzepatide or semaglutide

Some patients benefit from a slightly higher dose, while others do well with subtle timing shifts or consistent meal-spacing patterns that align with semaglutide's peak activity window

Originally developed to treat Type 2 diabetes under the names Ozempic and Weygovy, Semaglutide is now taking center stage as a treatment for obesity and excess weight

Yeghiazarians Y, Jneid H, Tietjens JR, et al

Personalized GLP-1 Therapy: Reducing Side Effects Through Genetic Insight PlexusDx uses the Precision Peptide Genetic Testa $99 add-on after your first month of treatmentto analyze how your specific genetic makeup influences peptide signaling pathways